45%), with a nonsignificant trend towards improved response rates [ 61 ].
← all excerpts
Clinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis.
1
—
—
45%), with a nonsignificant trend towards improved response rates [ 61 ].